Literature DB >> 20616345

Role of Cripto-1 in stem cell maintenance and malignant progression.

Caterina Bianco1, Maria Cristina Rangel, Nadia P Castro, Tadahiro Nagaoka, Kelly Rollman, Monica Gonzales, David S Salomon.   

Abstract

Cripto-1 is critical for early embryonic development and, together with its ligand Nodal, has been found to be associated with the undifferentiated status of mouse and human embryonic stem cells. Like other embryonic genes, Cripto-1 performs important roles in the formation and progression of several types of human tumors, stimulating cell proliferation, migration, epithelial to mesenchymal transition, and tumor angiogenesis. Several studies have demonstrated that cell fate regulation during embryonic development and cell transformation during oncogenesis share common signaling pathways, suggesting that uncontrolled activation of embryonic signaling pathways might drive cell transformation and tumor progression in adult tissues. Here we review our current understanding of how Cripto-1 controls stem cell biology and how it integrates with other major embryonic signaling pathways. Because many cancers are thought to derive from a subpopulation of cancer stem-like cells, which may re-express embryonic genes, Cripto-1 signaling may drive tumor growth through the generation or expansion of tumor initiating cells bearing stem-like characteristics. Therefore, the Cripto-1/Nodal signaling may represent an attractive target for treatment in cancer, leading to the elimination of undifferentiated stem-like tumor initiating cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20616345      PMCID: PMC2913337          DOI: 10.2353/ajpath.2010.100102

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  69 in total

1.  Core transcriptional regulatory circuitry in human embryonic stem cells.

Authors:  Laurie A Boyer; Tong Ihn Lee; Megan F Cole; Sarah E Johnstone; Stuart S Levine; Jacob P Zucker; Matthew G Guenther; Roshan M Kumar; Heather L Murray; Richard G Jenner; David K Gifford; Douglas A Melton; Rudolf Jaenisch; Richard A Young
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

Review 2.  Human embryonic stem cells: lessons from stem cell niches in vivo.

Authors:  Sean C Bendall; Morag H Stewart; Mickie Bhatia
Journal:  Regen Med       Date:  2008-05       Impact factor: 3.806

3.  Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis.

Authors:  Youping Sun; Luigi Strizzi; Ahmed Raafat; Morihisa Hirota; Caterina Bianco; Lionel Feigenbaum; Nicholas Kenney; Christian Wechselberger; Robert Callahan; David S Salomon
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

Review 4.  Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis.

Authors:  Luigi Strizzi; Caterina Bianco; Nicola Normanno; David Salomon
Journal:  Oncogene       Date:  2005-08-29       Impact factor: 9.867

Review 5.  Cripto-1: an oncofetal gene with many faces.

Authors:  Caterina Bianco; Luigi Strizzi; Nicola Normanno; Nadia Khan; David S Salomon
Journal:  Curr Top Dev Biol       Date:  2005       Impact factor: 4.897

6.  Human Cripto-1 overexpression in the mouse mammary gland results in the development of hyperplasia and adenocarcinoma.

Authors:  Christian Wechselberger; Luigi Strizzi; Nicholas Kenney; Morihisa Hirota; Youping Sun; Andreas Ebert; Olivia Orozco; Caterina Bianco; Nadia I Khan; Brenda Wallace-Jones; Nicola Normanno; Heather Adkins; Michele Sanicola; David S Salomon
Journal:  Oncogene       Date:  2005-06-09       Impact factor: 9.867

7.  Tcf3 is an integral component of the core regulatory circuitry of embryonic stem cells.

Authors:  Megan F Cole; Sarah E Johnstone; Jamie J Newman; Michael H Kagey; Richard A Young
Journal:  Genes Dev       Date:  2008-03-15       Impact factor: 11.361

8.  Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells.

Authors:  Lynne-Marie Postovit; Naira V Margaryan; Elisabeth A Seftor; Dawn A Kirschmann; Alina Lipavsky; William W Wheaton; Daniel E Abbott; Richard E B Seftor; Mary J C Hendrix
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-11       Impact factor: 11.205

9.  Teratocarcinoma-derived growth factor 1 (TDGF1) sequence variants in patients with congenital heart defect.

Authors:  Binbin Wang; Jinting Yan; Zuoqi Peng; Jing Wang; Shiguo Liu; XiaoDong Xie; Xu Ma
Journal:  Int J Cardiol       Date:  2009-10-24       Impact factor: 4.164

10.  Regulation of human Cripto-1 gene expression by TGF-beta1 and BMP-4 in embryonal and colon cancer cells.

Authors:  Mario Mancino; Luigi Strizzi; Christian Wechselberger; Kazuhide Watanabe; Monica Gonzales; Shin Hamada; Nicola Normanno; David S Salomon; Caterina Bianco
Journal:  J Cell Physiol       Date:  2008-04       Impact factor: 6.384

View more
  50 in total

Review 1.  Cripto/GRP78 modulation of the TGF-β pathway in development and oncogenesis.

Authors:  Peter C Gray; Wylie Vale
Journal:  FEBS Lett       Date:  2012-02-01       Impact factor: 4.124

Review 2.  Targeting the embryonic gene Cripto-1 in cancer and beyond.

Authors:  Caterina Bianco; David S Salomon
Journal:  Expert Opin Ther Pat       Date:  2010-11-13       Impact factor: 6.674

Review 3.  The multifaceted role of the embryonic gene Cripto-1 in cancer, stem cells and epithelial-mesenchymal transition.

Authors:  Malgorzata Klauzinska; Nadia P Castro; Maria Cristina Rangel; Benjamin T Spike; Peter C Gray; Daniel Bertolette; Frank Cuttitta; David Salomon
Journal:  Semin Cancer Biol       Date:  2014-08-19       Impact factor: 15.707

4.  Neuregulin-1β induces proliferation, survival and paracrine signaling in normal human cardiac ventricular fibroblasts.

Authors:  Annet Kirabo; Sergey Ryzhov; Manisha Gupte; Seng Sengsayadeth; Richard J Gumina; Douglas B Sawyer; Cristi L Galindo
Journal:  J Mol Cell Cardiol       Date:  2017-03-03       Impact factor: 5.000

5.  Reactivation of embryonic nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cells.

Authors:  Mitchell G Lawrence; Naira V Margaryan; Daniela Loessner; Angus Collins; Kris M Kerr; Megan Turner; Elisabeth A Seftor; Carson R Stephens; John Lai; Lynne-Marie Postovit; Judith A Clements; Mary J C Hendrix
Journal:  Prostate       Date:  2011-01-12       Impact factor: 4.104

6.  Sulforaphane Suppresses the Growth of Triple-negative Breast Cancer Stem-like Cells In vitro and In vivo.

Authors:  Nadia P Castro; Maria C Rangel; Anand S Merchant; Gabriel MacKinnon; Frank Cuttitta; David S Salomon; Young S Kim
Journal:  Cancer Prev Res (Phila)       Date:  2019-01-24

7.  CRISPR Technology for Breast Cancer: Diagnostics, Modeling, and Therapy.

Authors:  Rachel L Mintz; Madeleine A Gao; Kahmun Lo; Yeh-Hsing Lao; Mingqiang Li; Kam W Leong
Journal:  Adv Biosyst       Date:  2018-08-17

8.  Age-Dependent Association between Protein Expression of the Embryonic Stem Cell Marker Cripto-1 and Survival of Glioblastoma Patients.

Authors:  Berit B Tysnes; Hege A Satran; Sverre J Mork; Naira V Margaryan; Geir E Eide; Kjell Petersen; Luigi Strizzi; Mary J C Hendrix
Journal:  Transl Oncol       Date:  2013-12-01       Impact factor: 4.243

Review 9.  Beyond TGFβ: roles of other TGFβ superfamily members in cancer.

Authors:  Lalage M Wakefield; Caroline S Hill
Journal:  Nat Rev Cancer       Date:  2013-05       Impact factor: 60.716

10.  Cripto: Expression, epigenetic regulation and potential diagnostic use in testicular germ cell tumors.

Authors:  Cassy M Spiller; Ad J M Gillis; Guillaume Burnet; Hans Stoop; Peter Koopman; Josephine Bowles; Leendert H J Looijenga
Journal:  Mol Oncol       Date:  2015-11-18       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.